Provided by Tiger Trade Technology Pte. Ltd.

Cardiol Therapeutics Inc

1.41
-0.1500-9.62%
Post-market: 1.410.00000.00%18:03 EDT
Volume:3.59M
Turnover:5.32M
Market Cap:172.02M
PE:-5.97
High:1.64
Open:1.60
Low:1.40
Close:1.56
52wk High:2.34
52wk Low:0.8800
Shares:122.00M
Float Shares:96.67M
Volume Ratio:3.79
T/O Rate:3.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2360
EPS(LYR):-0.2835
ROE:-190.18%
ROA:-90.92%
PB:10.20
PE(LYR):-4.97

Loading ...

Company Profile

Company Name:
Cardiol Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
18
Office Location:
2265 Upper Middle Road East,Suite 602,Oakville,Ontario,Canada
Zip Code:
L6H 0G5
Fax:
- -
Introduction:
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.